Citation Impact
Citing Papers
COMPARISON OF THE EFFECT OF NEONATAL ADMINISTRATION OF TESTOSTERONE AND DIHYDROTESTOSTERONE IN THE FEMALE RAT
1972
Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer
1999 Standout
Concurrent overexpression of p53 and c-erbB-2 correlates with accelerated cycling and concomitant poor prognosis in node-negative breast cancer
2001
Untangling the ErbB signalling network
2001 Standout
Genomic and proteomic profiling I: Leiomyomas in African Americans and Caucasians
2007 Standout
Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence
2007 Standout
ERBB2 amplification is associated with tamoxifen resistance in steroid-receptor positive breast cancer
1994
Correlation between p53, c-erbB-2, and topoisomerase II? expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: prognostic implications
1999
High‐throughput protein expression analysis using tissue microarray technology of a large well‐characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses
2005
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials
2011 Standout
Triple-Negative Breast Cancer
2010 Standout
Levels of hypoxia‐inducible factor‐1α independently predict prognosis in patients with lymph node negative breast carcinoma
2003 StandoutNobel
Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype
2008 Standout
The Formation of Estrogens by Central Neuroendocrine Tissues
1975
Stromal fibroblasts in cancer initiation and progression
2004 StandoutNature
Estrogen Receptors: How Do They Signal and What Are Their Targets
2007 Standout
Expression of luminal and basal cytokeratins in human breast carcinoma
2004
Indicators of Prognosis in Node-Negative Breast Cancer
1990
Cisplatin: mode of cytotoxic action and molecular basis of resistance
2003 Standout
Reproductive Factors, Hormonal Contraception, and Risk of Uterine Leiomyomata in African-American Women: A Prospective Study
2004
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
Endometriosis
2009 Standout
Cryptorchidism in mice mutant for Insl3
1999 Standout
Back Pain During Pregnancy
1996
Molecular mechanisms of resistance and toxicity associated with platinating agents
2006 Standout
European guidelines for the diagnosis and treatment of pelvic girdle pain
2008 Standout
Histologic types and hormone receptors in breast cancer in men: a population-based study in 282 United States men
1993
Breast carcinoma in men
2004 Standout
The development of androgen-independent prostate cancer
2001 Standout
Clinical practice guidelines for the care and treatment of breast cancer: 16. Locoregional post-mastectomy radiotherapy
2004
Scanning electron microscopy shows inhibited gubernacular development in relation to undescended testes in oestrogen‐treated mice
1996
The urokinase-type plasminogen activator system in cancer metastasis: A review
1997 Standout
Dose-Dependent Alterations in Androgen-Regulated Male Reproductive Development in Rats Exposed to Di(n-butyl) Phthalate during Late Gestation
2000 Standout
Tissue microarrays for high-throughput molecular profiling of tumor specimens
1998 Standout
Cellular processing of platinum anticancer drugs
2005 Standout
Male breast cancer
2006 Standout
Hormone receptors in malignancy
1992
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma.
1998
Elagolix Treatment for Up to 12 Months in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas
2020 Standout
Ploidy, proliferative activity and prognosis. DNA flow cytometry of solid tumors
1990
Uterine fibroid management: from the present to the future
2016
Urokinase plasminogen activator, a strong independent prognostic factor in breast cancer, analysed in steroid receptor cytosols with a luminometric immunoassay
1996
Cisplatin: The first metal based anticancer drug
2019 Standout
Association of INT2/HST1 coamplification in primary breast cancer with hormone-dependent phenotype and poor prognosis
1991
Long-term follow-up of the randomized Stockholm trial on adjuvant tamoxifen among postmenopausal patients with early stage breast cancer
2006
The Ki-67 protein: From the known and the unknown
2000 Standout
Identification of genes with higher expression in human uterine leiomyomas than in the corresponding myometrium
2002
Oestrogen Receptor Analysis of Paraffin Sections and Cytosol Samples of Primary Breast Cancer in Relation to Outcome After Adjuvant Tamoxifen Treatment
1996
Production and Actions of Estrogens
2002 Standout
An ambulatory surgical procedure under local anesthesia for treatment of female urinary incontinence
1996 Standout
Immunohistochemistry compared to cytosol assays for determination of estrogen receptor and prediction of the long-term effect of adjuvant tamoxifen
2010
Distribution of androgen and estrogen receptor mRNA‐containing cells in the rat brain: An in situ hybridization study
1990 Standout
Time‐Dependent ROC Curves for Censored Survival Data and a Diagnostic Marker
2000 Standout
Endocrine Disruption in Wildlife: A Critical Review of the Evidence
1998 Standout
AN INTEGRAL THEORY OF FEMALE URINARY INCONTINENCE
1990
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Biochemical Modulation of Cisplatin Mechanisms of Action: Enhancement of Antitumor Activity and Circumvention of Drug Resistance
2003 Standout
Biologic Correlates of 18Fluorodeoxyglucose Uptake in Human Breast Cancer Measured by Positron Emission Tomography
2002 StandoutNobel
Breast Cancer Among the Oldest Old: Tumor Characteristics, Treatment Choices, and Survival
2010
Alterations in DNA Methylation: A Fundamental Aspect of Neoplasia
1997 Standout
Latent Effects of Pesticides and Toxic Substances On Sexual Differentiation of Rodents
1996
Aspects of Androgen-Dependent Events as Studied by Antiandrogens
1970
Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us?
1999 Standout
Mesenchymal-Epithelial Interactions in the Growth and Development of the Prostate
1989
Immunocytochemical analysis of estrogen receptors as a predictor of prognosis in breast cancer patients: comparison with quantitative biochemical methods.
1989
HER2 (neu) Signaling Increases the Rate of Hypoxia-Inducible Factor 1α (HIF-1α) Synthesis: Novel Mechanism for HIF-1-Mediated Vascular Endothelial Growth Factor Expression
2001 StandoutNobel
Selective Progesterone Receptor Modulator Development and Use in the Treatment of Leiomyomata and Endometriosis
2005
Estrogen Induces Axonal Outgrowth in the Nucleus Retroambiguus–Lumbosacral Motoneuronal Pathway in the Adult Female Cat
1997
Steroid hormones induce HMG1 overexpression and sensitize breast cancer cells to cisplatin and carboplatin
2000
Breast Cancer Risk Following Bilateral Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: An International Case-Control Study
2005 Standout
The effect of oestradiol on the DNA synthesis in neonatal mouse uterus and cervix
1975
A BIPHASIC MODEL FOR THE HORMONAL CONTROL OF TESTICULAR DESCENT
1985
Epidemiology of uterine fibroids: a systematic review
2017 Standout
The pathogenesis of benign prostatic hyperplasia
1980 Standout
Tissue interactions between epithelium and mesenchyme of urogenital and integumental origin
1972
Does Locoregional Radiation Therapy Improve Survival in Breast Cancer? A Meta-Analysis
2000
The presence of (dA{middle dot}dT)20-25 tracts in the DNA of primitive eukaryotes
1976
Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials
2014 Standout
Characterization of RAD9 of Saccharomyces cerevisiae and evidence that its function acts posttranslationally in cell cycle arrest after DNA damage.
1990 StandoutNobel
Sexual Differentiation of the Central Nervous System
1981 StandoutScience
Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes
1998
Etiology and pathogenesis of uterine leiomyomas: a review.
2002
Epidemiologic and Molecular Prognostic Review of Glioblastoma
2014 Standout
Chromosomes and Neoplasia
1979
SEX‐HORMONE‐BINDING GLOBULIN
1974 Standout
Breast Cancer in Men
2002 Standout
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials
2005 Standout
Cloning Human Fetal γ Globin and Mouse α-Type Globin DNA: Preparation and Screening of Shotgun Collections
1978 StandoutScienceNobel
Works of A. Norgren being referenced
Sex Steroid Receptors in Human Myometrium and Fibroids: Changes during the Menstrual Cycle and Gonadotropin-Releasing Hormone Treatment1
1998
Localization of steroid hormone receptors in the pelvic muscles
1993
Steroid Hormone Receptors in Pelvic Muscles and Ligaments in Women
1990
Estrogen and Progesterone Receptor Analyses in More Than 4000 Human Breast Cancer Samples: A Study with Special Reference to Age at diagnosis and stability of analyses
1990
Prognostic significance of estrogen and progesterone receptors in stage ii breast cancer
1988
A comparison of two steroid receptor assays in breast cancer: dextran coated charcoal and isoelectric focusing.
1983
PSEUDODIPLOID KARYOTYPE IN A BREAST CARCINOMA
1974
Prognostic value of flow cytometrical DNA measurements in stage I-II endometrial carcinoma: correlations with steroid receptor concentration, tumor myometrial invasion, and degree of differentiation.
1987
Observations on wet weight, protein and DNA as reference for steroid receptors in malignant mammary tumours.
1986
Improved method for assay of estradiol and progesterone receptors with special reference to breast cancer.
1983
Modifications of reproductive organs in male rats influenced prenatally or pre-and postnatally by an ?antiandrogenic? steroid (Cyproterone)
1968
Reactions of the vaginal plate and the vaginal epithelium to oestradiol monopropionate given once to 5 or 26-day old rats
1968
Hybridization of polyuridylic acid to human DNA immobilized onto nitrocellulose filters
1975
Menopausal status and cut off levels of steroid receptor ligand binding assays in breast cancer.
1989
EFFECTS OF NEONATALLY INJECTED NON-ESTERIFIED TESTOSTERONE ON REPRODUCTIVE FUNCTIONS IN FEMALE RATS
1971
Postoperative Radiation Therapy in Mammary Carcinoma Stage II: Target volume, organs at risk, absorbed dose, time-dose schedule, and dose to organs at risk in a prospective investigation
1979
Development of the urogenital tract in male offspring of rats injected during pregnancy with a substance with antiandrogenic properties (Cyproterone)
1968